FDA warns Arizona firm over numerous alleged disease claims

By Hank Schultz

- Last updated on GMT

©Getty Images - Ildo Frazao
©Getty Images - Ildo Frazao

Related tags regulations Regulation disease claims

An Arizona supplement marketer has been warned by FDA over claims relating to blood sugar management, stress relief, immunity and more.

The US Food and Drug Administration sent a warning letter to ICL Health, LLC, based in Tucson.  The company markets several supplements, all attributed to the company’s principal, Dr James L. Wilson, ND.

Among the products cited in the warning letter are Good Sugar, a blood sugar management product featuring minerals and herbs, Super Immune Space Sprinkles, an immunity product aimed at children, Super Immune Space Sprinkles, Cortisol Stress Reset, Nat-Stim and others.

The warning letter claims that the company was making claims to treat a host of conditions, including alcoholism, autoimmune diseases, fibromyalgia, depression and rheumatoid arthritis.

Specific claims

Among some of the many specific claims for ingredients and formulas cited by the Agency were these:

  • “Some researchers believe this [L-Lysine’s] ability to save off outbreaks also helps in the prevention of many other diseases related to cranial nerves such as migraines, Meniere’s disease, and Bell’s palsy.”
  • “[Ingredient(s) in Dr. Wilson’s Nat-Stim are] essential for immune function . . . . Stress and Immune Function . . . With chronic stress, this cortisol-related decrease in immune function can leave you more susceptible to colds, flu and other infections, and potentially make you more vulnerable to serious illness and degenerative disease down the road, as well as to the development of allergies and autoimmune disorders.”
  • “Can people with diabetes or metabolic syndrome take Dr. Wilson’s Good Sugar? . . . Diabetics and people with metabolic syndrome may find that Good Sugar . . . helps them feel their best.”

The warning letter resulted from a review of the company’s various websites, not a physical inspection.  FDA had given the company 15 days to respond from the issuance of the letter, which was dated Sept. 20, 2021.  The letter was posted on the FDA website on Oct. 5.

Related news

Show more

Related products

show more

LocVita® D3: Tailored Formulas & Beadlet Solutions

LocVita® D3: Tailored Formulas & Beadlet Solutions

Content provided by INNOBIO Corporation Limited | 11-Mar-2024 | White Paper

LocVita® Vegan Vitamin D3 delivers specially formulated options that are sugar-free and organic, designed to accommodate various dietary preferences and...

MOROSIL:INGREDIENT OF THE YEAR

MOROSIL:INGREDIENT OF THE YEAR

Content provided by BIONAP BIOACTIVE NATURAL PRODUCTS | 07-Mar-2024 | Product Brochure

MOROSIL™ has won as Ingredient of the Year in the category Weight Management at 2023 Nutraingredient USA. MOROSIL ™ is a standardized extract derived from...

Consumers' growing demand for Omegas

Consumers' growing demand for Omegas

Content provided by Fruit d'Or | 13-Feb-2024 | White Paper

Consumers are increasingly interested in the benefits of omegas supplements. According to forecasts for 2023–2030, the global omega-3 market is expected...

Curcumin may support cognitive, brain & mood benefits

Curcumin may support cognitive, brain & mood benefits

Content provided by Verdure Sciences | 02-Feb-2024 | White Paper

Cognitive health, mental acuity and brain support categories have seen tremendous growth. With an aging population and increased interest from formulators...

Related suppliers

Follow us

Products

View more

Webinars